Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A two-stage case-control study of EGFR polymorphisms and breast cancer risk.

Literature DB >> 19190167

A two-stage case-control study of EGFR polymorphisms and breast cancer risk.

Young-Seoub Hong¹, Sandra L Deming, Yu-Tang Gao, Ji-Rong Long, Xiao-Ou Shu, Qiuyin Cai, Wei Lu, Wei Zheng.

Abstract

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Substances：
ErbB Receptors

Year: 2009 PMID： 19190167 PMCID： PMC2702716 DOI： 10.1158/1055-9965.EPI-08-0961

Source DB: PubMed Journal: Cancer Epidemiol Biomarkers Prev ISSN： 1055-9965 Impact factor: 4.254

× No keyword cloud information.

16 in total

Review 1. A systematic review of genetic polymorphisms and breast cancer risk.

Authors: A M Dunning; C S Healey; P D Pharoah; M D Teare; B A Ponder; D F Easton
Journal: Cancer Epidemiol Biomarkers Prev Date: 1999-10 Impact factor: 4.254

2. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.

Authors: F Gebhardt; K S Zänker; B Brandt
Journal: J Biol Chem Date: 1999-05-07 Impact factor: 5.157

3. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay.

Authors: Paul Hardenbol; Fuli Yu; John Belmont; Jennifer Mackenzie; Carsten Bruckner; Tiffany Brundage; Andrew Boudreau; Steve Chow; Jim Eberle; Ayca Erbilgin; Mat Falkowski; Ron Fitzgerald; Sy Ghose; Oleg Iartchouk; Maneesh Jain; George Karlin-Neumann; Xiuhua Lu; Xin Miao; Bridget Moore; Martin Moorhead; Eugeni Namsaraev; Shiran Pasternak; Eunice Prakash; Karen Tran; Zhiyong Wang; Hywel B Jones; Ronald W Davis; Thomas D Willis; Richard A Gibbs
Journal: Genome Res Date: 2005-02 Impact factor: 9.043

4. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer.

Authors: Su Jeong Lee; Kyung Mee Kim; Myung Hwa Chae; Won Kee Lee; Sin Kam; Sung Ick Cha; Hyung Soo Han; Chang Ho Kim; Young Mo Kang; Sung Beom Han; Jae Yong Park
Journal: Cancer Genet Cytogenet Date: 2007-01-01

Review 5. Biomarkers and multiple drug resistance in breast cancer.

Authors: L O'Driscoll; M Clynes
Journal: Curr Cancer Drug Targets Date: 2006-08 Impact factor: 3.428

6. Association of the EGFR intron 1 CA repeat length with lung cancer risk.

Authors: Weiping Zhang; Joel L Weissfeld; Marjorie Romkes; Stephanie R Land; Jennifer R Grandis; Jill M Siegfried
Journal: Mol Carcinog Date: 2007-05 Impact factor: 4.784

7. Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma.

Authors: C Carpentier; F Laigle-Donadey; Y Marie; N Auger; A Benouaich-Amiel; J Lejeune; G Kaloshi; J-Y Delattre; J Thillet; M Sanson
Journal: Neurology Date: 2006-08-02 Impact factor: 9.910

8. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

Authors: Wanqing Liu; Federico Innocenti; Michael H Wu; Apurva A Desai; M Eileen Dolan; Edwin H Cook; Mark J Ratain
Journal: Cancer Res Date: 2005-01-01 Impact factor: 12.701

9. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study.

Authors: Y T Gao; X O Shu; Q Dai; J D Potter; L A Brinton; W Wen; T A Sellers; L H Kushi; Z Ruan; R M Bostick; F Jin; W Zheng
Journal: Int J Cancer Date: 2000-07-15 Impact factor: 7.396

10. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.

Authors: Paul I W de Bakker; Gil McVean; Pardis C Sabeti; Marcos M Miretti; Todd Green; Jonathan Marchini; Xiayi Ke; Alienke J Monsuur; Pamela Whittaker; Marcos Delgado; Jonathan Morrison; Angela Richardson; Emily C Walsh; Xiaojiang Gao; Luana Galver; John Hart; David A Hafler; Margaret Pericak-Vance; John A Todd; Mark J Daly; John Trowsdale; Cisca Wijmenga; Tim J Vyse; Stephan Beck; Sarah Shaw Murray; Mary Carrington; Simon Gregory; Panos Deloukas; John D Rioux
Journal: Nat Genet Date: 2006-09-24 Impact factor: 38.330

7 in total

1. The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-Analysis.

Authors: Jianjun Jiang; Yanjiao Li; Lifen Dai; Haiying Wu; Min Hu
Journal: Int J Genomics Date: 2015-03-19 Impact factor: 2.326

2. Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer.

Authors: Ranbir Chander Sobti; Marjan Askari; Mohsen Nikbakht; Neha Singh; Suresh C Sharma; Abayneh Munshea Abitew
Journal: Mol Cell Biochem Date: 2012-07-19 Impact factor: 3.396

3. Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.

Authors: Avonne E Connor; Richard N Baumgartner; Kathy B Baumgartner; Christina M Pinkston; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery
Journal: Int J Mol Epidemiol Genet Date: 2013-11-28

4. Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.

Authors: Christopher Fung; Pei Zhou; Sonali Joyce; Kerry Trent; Jian-Min Yuan; Jennifer R Grandis; Joel L Weissfeld; Marjorie Romkes; Daniel E Weeks; Ann Marie Egloff
Journal: Cancer Lett Date: 2014-12-12 Impact factor: 8.679